E-LIB Suche - Ergebnisse für: Erba, H.

1

P584: OVERALL SURVIVAL WITH INTENSIVE CHEMOTHERAPY (IC) VS ..:

Erba, H. ; Pollyea, D. ; Sekeres, M....
HemaSphere. 6 (2022) - p. 483-484 , 2022

Link: https://doi.org/10.1097/..

2

S100: QUIZARTINIB PROLONGED SURVIVAL VS PLACEBO PLUS INTENS..:

Erba, H. ; Montesinos, P. ; Vrhovac, R....
HemaSphere. 6 (2022) - p. 1-2 , 2022

Link: https://doi.org/10.1097/..

3

Prediction of CR following a second course of '7+3' in pati..:

Othus, M ; Mukherjee, S ; Sekeres, M A...
Leukemia. 30 (2016) 8 - p. 1779-1780 , 2016

Link: https://doi.org/10.1038/..

4

249 CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS..:

Steensma, D. ; Abedi, M. ; Bejar, R....
Leukemia Research. 39 (2015) - p. S124 , 2015

Link: https://doi.org/10.1016/..

5

P-124 Application of the French Prognostic Score to assess ..:

Zeidan, A. ; Zhuoxin, S. ; Prebet, T....
Leukemia Research. 37 (2013) - p. S79-S80 , 2013

Link: https://doi.org/10.1016/..

6

170 Azacitidine plus entinostat: Results from E1905, the fi..:

Gore, S. ; Sun, Z. ; Prebet, T....
Leukemia Research. 35 (2011) - p. S66-S67 , 2011

Link: https://doi.org/10.1016/..

7

299 SOCS1 methylation and azacitidine response in high risk..:

Prebet, T. ; Sun, Z. ; Carraway, H....
Leukemia Research. 35 (2011) - p. S118 , 2011

Link: https://doi.org/10.1016/..

8

P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT..:

McCloskey, J. ; Pullarkat, V. ; Mannis, G....
HemaSphere. 6 (2022) - p. 413-414 , 2022

Link: https://doi.org/10.1097/..

9

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMG..:

Pemmaraju, N. ; Martinelli, G. ; Todisco, E....
HemaSphere. 6 (2022) - p. 1708-1709 , 2022

Link: https://doi.org/10.1097/..

10

P765: UPDATED ENROLLMENT AND RESULTS FROM THE PHASE 1 SUBST..:

DiNardo, C. D. ; Foran, J. M. ; Watts, J. M....
HemaSphere. 6 (2022) - p. 660-661 , 2022

Link: https://doi.org/10.1097/..

11

P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DR..:

Daver, N. G. ; Montesinos, P. ; Aribi, A....
HemaSphere. 6 (2022) - p. 454-455 , 2022

Link: https://doi.org/10.1097/..

12

Expanded safety analysis of pevonedistat, a first-in-class ..:

Swords, R T ; Watts, J ; Erba, H P...
Blood Cancer Journal. 7 (2017) 2 - p. e520-e520 , 2017

Link: https://doi.org/10.1038/..

13

Current Diagnosis Patterns for Acute Myeloid Leukemia: Conc..:

George, T.I. ; Erba, H.P. ; Pollyea, D.A....
Leukemia Research. 55 (2017) - p. S106 , 2017

Link: https://doi.org/10.1016/..

14

Effect of measurable ('minimal') residual disease (MRD) inf..:

Othus, M ; Wood, B L ; Stirewalt, D L...
Leukemia. 30 (2016) 10 - p. 2080-2083 , 2016

Link: https://doi.org/10.1038/..

15

Conditioning with Clofarabine and Busulfan X 4 (CloBu4) For..:

Magenau, J. ; Pawarode, A. ; Buck, T....
Biology of Blood and Marrow Transplantation. 15 (2009) 2 - p. 104 , 2009

Link: https://doi.org/10.1016/..